A startup working on a shelf-stable skin patch to deliver vaccines and drugs has named a longtime Genzyme veteran as its new leader, as well as $12 million in funding.

Rachel Sha is the new CEO of Vaxess Technologies Inc. From the Boston Business Journal. A Cambridge, Mass. startup working on a shelf-stable skin patch to deliver vaccines and drugs has brought in ...